Clinical Trials Directory

Trials / Completed

CompletedNCT07379892

Evaluatıon of TREM-1, MMP-8 and TIMP-1 Levels in Perı-Implant Crevicular Fluıd of Perı-Implanted Indıvıduals

Status
Completed
Phase
Study type
Observational
Enrollment
54 (actual)
Sponsor
Aydin Adnan Menderes University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The aim of this study was to evaluate the relationship between Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1), Matrix Metalloproteinases-8 (MMP-8) and Tissue Inhibitors of Metalloproteinases-1 (TIMP-1) levels in peri-implant crevicular fluid (PICF) in peri-implantitis patients.

Detailed description

The aim of this study was to evaluate the relationship between TREM-1, MMP-8 and TIMP-1 levels in peri-implant crevicular fluid (PICF) in patients with peri-implantitis, and the correlation of these markers with clinical periodontal parameters.

Conditions

Interventions

TypeNameDescription
OTHERCollection of PICF samplesTREM-1, MMP-8 and TIPM-1 levels reseach in PICF samples

Timeline

Start date
2023-06-01
Primary completion
2023-12-15
Completion
2024-05-20
First posted
2026-02-02
Last updated
2026-02-09

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07379892. Inclusion in this directory is not an endorsement.